UnknownNot Applicable

Cell-free Tumor DNA in Head and Neck Cancer Patients

Denmark500 participantsStarted 2017-02-01

Plain-language summary

This study investigates if head and neck squamous cell carcinoma can be tracked with cell-free tumor DNA, RNA or HPV-DNA, in blood samples from patients referred with suspicion of cancer, and if it can be used in detecting recurrence in patients already diagnosed and treated for head and neck squamous cell carcinoma.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients 18 years old or older * Suspicion of head and neck cancer Exclusion Criteria: * Diagnosed with cancer within the last 3 years ( apart from basal cell carcinoma) * Diagnosed with an inflammatory or haematological disease after the age of 18 * Received chemotherapy or immunosuppressive treatment within the last 3 years * Underwent a FNA ( fine-needle aspiration biopsy) or a biopsy from the head and neck region within 1 week.

What they're measuring

Percentage of head and neck cancer detected with a blood sample

Timeframe: 0 months

Percentage of head and neck cancer recurrence detected with a blood sample

Timeframe: 36 months

Trial details

NCT IDNCT03942380

SponsorChristian von Buchwald

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-01

Contact for this trial

Christian Grønhøj, MD, Ph.D

004526276374 Christian.groenhoej@regionh.dk

View on ClinicalTrials.gov More Head and Neck Cancer trials